Vimarsana
Biggest News Aggregation in the World

Page 2 - Path Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Path Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Path Inc Today - Breaking & Trending Today

Artisan Partners Limited Partnership Takes $48.27 Million Position in UiPath Inc. (NYSE:PATH) - Vimarsana News

Artisan Partners Limited Partnership Takes $48.27 Million Position in UiPath Inc. (NYSE:PATH)

Artisan Partners Limited Partnership acquired a new stake in shares of UiPath Inc. (NYSE:PATH – Free Report) in the 4th quarter, HoldingsChannel reports. The fund acquired 1,943,121 shares of the healthcare company’s stock, valued at approximately $48,267,000. Several other hedge funds and other institutional investors have also recently modified their holdings of PATH. Principal Financial […]

Beyond The Numbers: 20 Analysts Discuss UiPath Stock - UiPath (NYSE:PATH) - Vimarsana News

Beyond The Numbers: 20 Analysts Discuss UiPath Stock - UiPath (NYSE:PATH)

UiPath (NYSE:PATH) Trading Down 0.8% - Vimarsana News

UiPath (NYSE:PATH) Trading Down 0.8%

UiPath Inc. (NYSE:PATH – Get Free Report)’s stock price traded down 0.8% during mid-day trading on Tuesday . The company traded as low as $18.49 and last traded at $18.83. 3,701,516 shares changed hands during mid-day trading, a decline of 54% from the average session volume of 7,962,141 shares. The stock had previously closed at […]

Source: wkrb13.com
A Closer Look at UiPath's Options Market Dynamics - UiPath (NYSE:PATH) - Vimarsana News

A Closer Look at UiPath's Options Market Dynamics - UiPath (NYSE:PATH)

Deuterium Capital Management LLC Invests $497,000 in UiPath Inc. (NYSE:PATH) - Vimarsana News

Deuterium Capital Management LLC Invests $497,000 in UiPath Inc. (NYSE:PATH)

Deuterium Capital Management LLC bought a new stake in shares of UiPath Inc. (NYSE:PATH – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 20,000 shares of the healthcare company’s stock, valued at approximately $497,000. UiPath accounts for approximately 1.6% of […]